L6: modulation of pain using lifestyle and psychological approaches

What is exercise-induced hypoalgesia (EIH), and why is it important in chronic pain?

Exercise-induced hypoalgesia (EIH) refers to a reduction in pain sensitivity following physical activity.

• In many individuals, exercise produces a temporary analgesic effect. • However, EIH is not universal in chronic pain populations, and some patients experience increased pain sensitivity or symptom flare-ups after exertion. • Acute exercise responses may therefore differ from the longer-term benefits of regular physical activity.

Clinical implication: Exercise should be individually tailored rather than assumed to produce immediate analgesia in everyone.

Through which biological mechanisms may physical activity modulate pain?

1. Descending pain modulation: • Exercise is associated with enhanced endogenous pain inhibition and reduced pain facilitation, potentially shifting the nervous system away from a sensitised state.

2. Immune and inflammatory regulation: • Regular activity may reduce pro-inflammatory signalling and improve immune regulation, potentially influencing processes involved in chronic pain maintenance.

3. Changes in pain sensitivity: • Exercise can produce exercise-induced hypoalgesia, although responses vary between individuals and clinical populations.

Overall, physical activity may influence central pain processing as well as peripheral physical functioning. These are proposed and supported mechanisms rather than effects established in every patient.

How can physical activity improve chronic pain through psychological mechanisms?

• Reduced fear-avoidance: Successful experiences of movement may challenge beliefs that activity necessarily causes injury or harm. • Increased self-efficacy: Gradually achieving activity goals can strengthen confidence in the ability to function despite pain. • Improved mood and coping: Activity may reduce psychological distress and support adaptive pain management. • Reduced disability: Greater confidence and engagement can help patients resume meaningful daily activities.

This demonstrates that exercise is a biopsychosocial intervention rather than simply a way of improving muscle strength or fitness.

Why must the benefits of exercise for chronic pain be interpreted cautiously?

• Exercise-induced hypoalgesia is variable, and some patients experience increased pain following exertion. • Improvements in physical functioning, fear-avoidance and mood do not necessarily mean equivalent reductions in pain intensity. • Different chronic pain conditions and individuals may respond differently to the same exercise programme. • The lecture notes describe a 2020 meta-analysis reporting reduced fear-avoidance following exercise, but the certainty of evidence was very low to low.

Implication: Exercise is a useful component of chronic pain management, but claims about its effectiveness should distinguish pain relief from improvements in function and psychological wellbeing.

What is the fear-avoidance model proposed by Vlaeyen and Linton (2000)?

Vlaeyen and Linton (2000) reviewed the role of pain-related fear in the development and maintenance of chronic musculoskeletal pain and disability.

The model proposes two possible responses to pain.

1. Fear-avoidance pathway: • Catastrophic interpretations of pain promote fear of movement or reinjury. • Fear encourages hypervigilance, escape and avoidance. • Persistent avoidance can contribute to inactivity, disuse, psychological distress and disability.

2. Confrontation pathway: • Individuals who interpret pain as less threatening are more likely to confront activities and gradually resume normal functioning. • This allows recovery and reduces the likelihood that avoidance becomes persistent.

Central argument: Disability may be maintained partly by interpretations of pain and behavioural responses, not simply by the severity of nociceptive input.

How does the fear-avoidance model explain the transition from acute pain to persistent disability?

1. Pain is experienced following injury or another painful event.
2. Catastrophising increases the perceived threat of pain and potential reinjury.
3. Pain-related fear develops, encouraging hypervigilance and avoidance of movement.
4. Avoidance prevents the individual from discovering that some feared activities may be tolerable or safe.
5. Prolonged inactivity can contribute to deconditioning, reduced confidence, low mood and disability.
6. These consequences may reinforce the original perception of movement as threatening, maintaining the cycle.

Crucially, avoidance can occur in anticipation of pain rather than only in response to pain actually experienced.

What factors contribute to pain-related fear according to Vlaeyen and Linton (2000)?

The review identifies several possible vulnerability factors.

• Pain catastrophising: Exaggerated negative interpretations of pain and its consequences. • Anxiety sensitivity: Fear of anxiety-related bodily sensations. • Negative affectivity: A tendency towards negative emotional responses. • Traumatic or sudden pain onset: Experiences that may strengthen beliefs that pain signals serious threat.

These factors can influence how pain is interpreted and whether individuals respond through avoidance or confrontation.

They should be understood as potential contributors rather than inevitable causes of chronic pain disability.

What evidence discussed by Vlaeyen and Linton (2000) supports the importance of pain-related fear in disability?

The review discusses research associating pain-related fear with poorer physical performance, greater self-reported disability and work absence.

• Fearful patients may overpredict the pain associated with particular movements. • Anticipatory fear can lead to premature termination or avoidance of physical tasks. • Fear may also be associated with guarded movement and altered muscle activity. • In some findings, pain-related fear predicts functioning more strongly than pain intensity or biomedical indicators.

Interpretation: Cognitive and emotional responses to pain may contribute independently to disability, supporting interventions that target fear rather than pain intensity alone.

What physical and physiological consequences of fear-avoidance are discussed by Vlaeyen and Linton (2000)?

• Disuse and deconditioning: Prolonged inactivity can reduce physical endurance and contribute to muscle weakness. • Guarded movement: Patients may alter movement patterns to protect a body region they perceive as vulnerable. • Increased muscle tension: Feared movements may provoke elevated muscle activity or protective responses. • Reduced functional capacity: Avoidance can make ordinary activities increasingly difficult.

The review discusses altered paraspinal muscle activity and the flexion-relaxation phenomenon as examples of possible motor consequences.

These changes may reinforce disability, although the degree of physical deconditioning varies between patients.

How can pain-related fear and avoidance be assessed according to Vlaeyen and Linton (2000)?

Self-report measures include: • Tampa Scale for Kinesiophobia (TSK), assessing fear of movement and reinjury. • Fear-Avoidance Beliefs Questionnaire (FABQ), assessing beliefs about physical activity and work. • Pain Anxiety Symptoms Scale (PASS), assessing anxiety-related responses to pain.

Additional approaches include: • Behavioural observation of feared movements or tasks. • Psychophysiological measures such as muscle electromyography (EMG).

Using multiple assessment methods can help distinguish reported fear from actual avoidance behaviour and physiological responses.

How can graded exposure in vivo reduce fear-avoidance in chronic pain?

Graded exposure involves systematically confronting specific movements or activities that the patient fears.

1. Identify activities associated with fear of pain or reinjury.
2. Develop a hierarchy of feared activities.
3. Gradually practise these movements in a supported and tolerable way.
4. Compare anticipated harm with what actually occurs.
5. Use repeated experiences to challenge catastrophic beliefs and reduce avoidance.

Mechanism: Exposure creates opportunities for corrective learning, potentially weakening the association between movement and threat.

Clinical implication: Treatment aims to restore confidence and functioning rather than requiring pain to disappear before activity resumes.

What is the difference between graded activity and graded exposure in chronic pain rehabilitation?

Graded activity: • Progressively increases activity or functional goals according to an agreed plan. • Focuses on rebuilding tolerance, consistency and participation. • Is not necessarily organised around the patient's specific fears.

Graded exposure: • Specifically targets movements or activities perceived as threatening. • Uses a hierarchy of feared situations. • Focuses on reducing fear and avoidance through corrective experiences.

Both approaches can improve engagement in activity, but graded exposure is particularly relevant when fear of movement or reinjury is a major barrier.

What are the main barriers to physical activity adherence in chronic pain, and how can clinicians address them?

Barriers: • Fear of pain or reinjury. • Low self-efficacy and confidence in movement. • Pain flare-ups and fatigue. • Low mood or psychological distress. • Limited social support and practical access difficulties.

Clinical responses: • Tailor exercise to the individual's condition, preferences and goals. • Introduce manageable and progressive activity. • Use education and graded exposure when fear is prominent. • Consider pacing, sleep, stress and comorbidities. • Frame physical activity as a sustainable self-management strategy rather than a cure.

The goal is to make participation realistic and maintainable over time.

How can the fear-avoidance model of Vlaeyen and Linton (2000) be critically evaluated?

Strengths: • Provides a biopsychosocial explanation of how pain-related beliefs, emotions and behaviours may contribute to persistent disability. • Explains why patients with similar pain intensity may show different levels of functioning. • Offers a clear clinical rationale for targeting fear through graded exposure and movement-based rehabilitation.

Limitations: • The 2000 paper is a review and theoretical synthesis rather than a single experimental demonstration of the complete causal pathway. • Associations between fear, avoidance and disability do not establish that fear always causes disability. • Avoidance may sometimes be appropriate when movement presents genuine physical risk. • The model does not fully account for all biological, social and contextual contributors to chronic pain.

Essay implication: • The model supports targeting maladaptive pain-related fear, but interventions must distinguish disproportionate threat beliefs from legitimate activity limitations.

What is the bidirectional relationship between sleep disturbance and chronic pain?

Sleep disturbance and chronic pain can influence one another.

• Sleep disturbance → Pain: Poor or disrupted sleep may increase pain sensitivity, reduce tolerance of painful stimuli and contribute to the risk of developing chronic pain. • Pain → Sleep disturbance: Persistent pain can make it difficult to fall asleep, remain asleep or obtain restorative sleep. • These processes may reinforce one another, creating a cycle of poor sleep and worsening pain.

Implication: Sleep should be considered an important component of biopsychosocial pain management rather than simply a secondary symptom of chronic pain.

What was the aim and methodology of Chang et al. (2022)?

Chang et al. (2022) conducted a systematic review and meta-analysis investigating how different forms of experimental sleep deprivation influence pain perception.

• Included 31 experimental studies. • Covered 699 healthy individuals and 47 patients with chronic pain, including somatoform pain and rheumatoid arthritis. • Compared total sleep deprivation, partial sleep deprivation, selective sleep-stage deprivation and sleep fragmentation. • Examined pain thresholds, pain tolerance, spontaneous pain intensity and measures of central pain modulation.

Aim: To determine whether different forms of sleep disruption produce different effects on pain rather than treating all sleep deprivation as equivalent.

What are the four sleep deprivation paradigms examined by Chang et al. (2022)?

1. Total sleep deprivation: • Remaining awake continuously, typically for 24–72 hours.

2. Partial sleep deprivation: • Restricting sleep duration, for example to 2–6 hours per night over several days.

3. Selective sleep deprivation: • Interrupting particular sleep stages, such as REM or slow-wave sleep, using EEG-monitored awakenings.

4. Sleep fragmentation: • Repeatedly interrupting sleep with awakenings throughout the night.

These paradigms differ in how they disturb sleep and may therefore produce different effects on pain processing.

What did Chang et al. (2022) find about total sleep deprivation and pain?

In healthy participants, total sleep deprivation significantly reduced pain threshold and pain tolerance.

• Pain threshold: Pooled effect size = 0.74. • Pain tolerance: Pooled effect size = 0.95. • Effects were observed across several experimental pain modalities, including heat, cold and pressure.

However, the review did not find significant overall effects on spontaneous pain intensity or its assessed central sensitisation outcomes.

Limited evidence from chronic pain patients suggested that total sleep deprivation could increase spontaneous pain intensity.

Interpretation: Complete sleep loss can increase sensitivity to experimentally induced pain, but this does not establish identical effects across all pain outcomes or clinical populations.

What did Chang et al. (2022) find about partial sleep deprivation and pain?

Partial sleep deprivation involved restricting sleep to approximately 2–6 hours per night over 1–12 days.

• In healthy participants, partial sleep deprivation produced a small but statistically significant increase in spontaneous pain intensity, with a pooled effect size of 0.30. • The review did not identify significant overall changes in pain threshold or tolerance. • Evidence from patients with rheumatoid arthritis suggested increased spontaneous pain following partial sleep deprivation, although clinical evidence was very limited.

Interpretation: Even incomplete sleep loss may worsen everyday pain experiences, but its effects differ from those of total sleep deprivation.

What did Chang et al. (2022) find about selective sleep deprivation and pain?

Selective sleep deprivation involves interrupting particular sleep stages, such as REM sleep or slow-wave sleep.

Chang et al. (2022) reported that selective sleep-stage deprivation did not produce statistically significant overall changes in spontaneous pain intensity, pain threshold or pain tolerance among healthy participants.

However, evidence was limited, particularly for central pain sensitisation outcomes.

Interpretation: The available findings do not establish that depriving a particular sleep stage has no effect on pain. They indicate that consistent effects were not demonstrated in the included studies.

Why is sleep fragmentation particularly relevant to chronic pain according to Chang et al. (2022)?

Sleep fragmentation involves repeated awakenings that disrupt sleep continuity.

Chang et al. (2022) found that sleep fragmentation significantly reduced pain threshold and pain tolerance in healthy participants.

• Pain threshold: Pooled effect size = 0.42. • Pain tolerance: Pooled effect size = 0.79. • The review also discussed evidence suggesting changes in central pain facilitation and inhibition, although these findings were based on limited studies.

Clinical relevance: Repeated awakenings resemble sleep disruption experienced by some people with insomnia and chronic pain.

However, experimental fragmentation in healthy volunteers cannot be assumed to reproduce all features of clinical insomnia.

What overall conclusions can be drawn from Chang et al. (2022) about sleep deprivation and pain?

• Sleep deprivation generally increases sensitivity to pain, but the effects depend on the form of sleep disruption. • Total sleep deprivation showed substantial effects on experimental pain threshold and tolerance. • Partial sleep deprivation was associated with a smaller increase in spontaneous pain. • Sleep fragmentation reduced threshold and tolerance and may influence central pain modulation. • Selective sleep-stage deprivation did not show consistent significant effects in the available evidence.

Central conclusion: Sleep loss is not a single uniform exposure, and different sleep disturbances should not be treated as interchangeable when explaining pain mechanisms.

How can Chang et al. (2022) be critically evaluated?

Strengths: • Systematic review and meta-analysis of experimental studies, allowing comparison of different sleep deprivation protocols. • Experimental manipulation of sleep provides stronger evidence that sleep disruption can influence pain sensitivity than cross-sectional associations alone. • Considered multiple pain outcomes rather than assuming that threshold, tolerance and spontaneous pain are equivalent.

Limitations: • Most participants were healthy volunteers, with only 47 chronic pain patients represented. • Included studies were generally of low or moderate methodological quality. • Sleep deprivation protocols, pain stimuli and participant characteristics varied, introducing heterogeneity. • Some conclusions about central pain modulation and clinical pain relied on very few studies.

Essay implication: • Supports a causal influence of sleep disruption on experimental pain sensitivity, but generalisation to long-term chronic pain mechanisms requires caution.

What was the aim and methodology of Herrero Babiloni et al. (2025)?

Herrero Babiloni et al. (2025) investigated whether sleep-related problems predicted the development of chronic pain and high-impact chronic pain in US adults.

• Design: Prospective, nationally representative cohort study with approximately one year of follow-up. • Data source: US National Health Interview Survey. • Chronic pain incidence analysis: 7,826 adults without chronic pain at baseline. • High-impact chronic pain incidence analysis: 9,195 adults without high-impact chronic pain at baseline. • Exposures: Frequency of trouble sleeping and daytime tiredness. • Outcomes: New-onset chronic pain and high-impact chronic pain.

The prospective design allowed the researchers to examine whether sleep-related symptoms were associated with subsequent pain outcomes.

What did Herrero Babiloni et al. (2025) find about sleep problems and the incidence of chronic pain?

The study identified a dose-response association between more frequent sleep-related problems and greater incidence of chronic pain.

• One-year incidence of chronic pain was approximately 10.6%. • One-year incidence of high-impact chronic pain was approximately 4.2%. • Reporting trouble sleeping nearly every day was associated with a relative risk of 2.26 for incident chronic pain. • Frequent trouble sleeping was also associated with greater risk of high-impact chronic pain, with a relative risk of 2.62 for nearly daily sleep problems.

Interpretation: Frequent sleep difficulties prospectively predict greater chronic pain burden.

However, relative risks describe associations and do not establish that sleep problems directly caused the subsequent pain.

What did Herrero Babiloni et al. (2025) find about daytime tiredness and sociodemographic differences?

Daytime tiredness was associated with increased risk of developing chronic pain and high-impact chronic pain.

• Nearly daily tiredness was associated with relative risks of approximately 1.89–2.47 for chronic pain. • For high-impact chronic pain, corresponding relative risks were approximately 2.66–4.01. • The study reported variation in these associations across racial and ethnic groups, with particularly elevated estimates in some non-Hispanic Black and Asian subgroups. • No significant interaction effects were reported for age or sex.

Interpretation: Daytime tiredness and trouble sleeping are distinct indicators of future pain burden.

The subgroup findings should not be interpreted as evidence of inherent biological differences because social, environmental and healthcare factors may contribute.

How can Herrero Babiloni et al. (2025) be critically evaluated?

Strengths: • Large, nationally representative US cohort. • Prospective design established an association between reported sleep-related symptoms and later chronic pain outcomes. • Distinguished chronic pain from high-impact chronic pain, incorporating functional consequences. • Examined both nighttime sleep difficulties and daytime tiredness.

Limitations: • Sleep and pain were measured through self-report rather than objective sleep assessments. • Different recall periods for sleep and pain leave some uncertainty about temporal ordering and possible reverse causality. • Potential confounders such as detailed physical activity, sleep duration and pain characteristics were unavailable. • Observational findings cannot establish that treating sleep problems would prevent chronic pain. • Findings from US adults may not generalise fully to other healthcare and social contexts.

Essay implication: • Provides evidence that sleep-related symptoms are prospective markers of chronic pain risk, complementing experimental evidence that sleep loss increases pain sensitivity.

What is endogenous pain modulation (EPM), and how might sleep disturbance affect it?

Endogenous pain modulation (EPM) refers to the nervous system's ability to regulate nociceptive processing through inhibitory and facilitatory mechanisms.

• Pain inhibition: Neural processes suppress nociceptive signalling and reduce perceived pain. • Pain facilitation: Neural processes amplify nociceptive signalling and increase pain sensitivity.

Poor sleep may disrupt the balance between these processes, potentially reducing pain inhibition and increasing pain facilitation.

However, evidence that sleep disturbance consistently impairs EPM in humans is mixed.

What is conditioned pain modulation (CPM), and why is it relevant to the sleep–pain relationship?

Conditioned pain modulation (CPM) is an experimental measure of endogenous pain inhibition.

• A painful test stimulus is assessed before or during a separate conditioning stimulus, which is also painful. • The conditioning stimulus can reduce the perceived intensity of the test stimulus. • This is often described as a 'pain inhibits pain' effect.

Reduced CPM indicates weaker inhibition under the testing conditions.

Sleep disturbance has been proposed to impair CPM, potentially contributing to heightened pain sensitivity.

However, CPM is an indirect behavioural measure and does not identify the precise neural mechanism responsible.

What is temporal summation of pain (TSP), and how might it relate to sleep disturbance?

Temporal summation of pain (TSP) refers to an increase in perceived pain intensity when identical noxious stimuli are repeatedly delivered over a short period.

• It provides an experimental index of pain facilitation. • It is commonly linked to central excitability and spinal wind-up. • Greater TSP can indicate enhanced facilitatory processing.

Sleep disruption may increase pain facilitation, potentially producing greater TSP.

However, TSP is not a direct measurement of a single spinal mechanism, and evidence for a consistent effect of poor sleep on TSP remains mixed.

What was the aim and methodology of Herrero Babiloni et al. (2024)?

Herrero Babiloni et al. (2024) conducted a systematic review and meta-analysis examining associations between sleep disturbance and endogenous pain modulation.

• Included 37 studies in the qualitative synthesis. • Included 17 studies in quantitative meta-analyses. • Examined 17 studies involving healthy populations and 20 involving clinical populations. • Sleep disturbances included experimental sleep loss, poor sleep quality, short sleep duration and insomnia. • Main outcomes included conditioned pain modulation (CPM) and temporal summation of pain (TSP). • Offset analgesia was also considered, although only one included study assessed it.

Aim: To establish whether sleep disturbances are consistently associated with altered endogenous pain inhibition or facilitation.

What were the main findings of Herrero Babiloni et al. (2024) concerning sleep disturbance and endogenous pain modulation?

The findings differed between qualitative and quantitative analyses.

Qualitative findings: • Several individual studies associated poorer sleep with reduced pain inhibition, particularly weaker CPM. • Results for both CPM and TSP were mixed across healthy and clinical populations.

Quantitative findings: • The pooled meta-analyses did not demonstrate statistically significant overall associations between sleep disturbance and altered CPM or TSP in the main analyses.

Interpretation: • Individual findings suggest that sleep disturbance may compromise pain regulation. • However, the pooled evidence does not establish a consistent overall impairment of endogenous pain modulation.

This distinction is important because positive findings from individual studies should not be presented as a definitive meta-analytic conclusion.

What sex-related findings were reported by Herrero Babiloni et al. (2024)?

The review's sex-stratified analyses suggested that the relationship between experimental sleep disturbance and conditioned pain modulation differed between females and males.

• Female participants showed a statistically significant reduction in pain inhibition following experimental sleep disturbance. • The corresponding effect was not statistically significant in male participants.

Interpretation: • Biological sex may moderate the relationship between sleep loss and endogenous pain inhibition.

Critical caution: • A significant effect in one subgroup and a non-significant effect in another does not, by itself, establish a statistically significant difference between the groups. • The findings do not prove that all females are more vulnerable to sleep-related pain sensitisation or identify a definitive hormonal mechanism.

Why might sleep measurement methods influence findings on endogenous pain modulation?

Herrero Babiloni et al. (2024) noted that associations between sleep disturbance and pain modulation were detected more consistently in some studies using polysomnography (PSG).

• Polysomnography measures physiological aspects of sleep, including sleep stages and continuity. • Actigraphy estimates sleep and wake patterns from movement. • Self-report measures capture perceived sleep quality and sleep difficulties.

Different methods assess different aspects of sleep and may produce different associations with CPM or TSP.

Critical implication: • Variation in measurement methods contributes to difficulties comparing studies. • More frequent significant findings with PSG do not necessarily prove that PSG always detects genuine pain modulation deficits more accurately.

How can Herrero Babiloni et al. (2024) be critically evaluated?

Strengths: • Systematic review and meta-analysis integrating evidence from healthy and clinical populations. • Examined both pain inhibition and facilitation rather than treating endogenous pain modulation as one process. • Considered differences in sleep assessment methods and participant sex. • Distinguished qualitative findings from pooled statistical results.

Limitations: • Substantial heterogeneity in sleep disturbance protocols, pain testing procedures and clinical conditions. • Only 17 of the 37 included studies contributed to quantitative meta-analyses. • Limited evidence for some measures, including offset analgesia. • Subgroup findings may be based on smaller samples and require replication. • CPM and TSP are indirect experimental measures rather than direct recordings of descending pathways or spinal wind-up.

Essay implication: • The review supports investigating impaired endogenous pain regulation as a possible mechanism, but challenges the claim that poor sleep consistently produces measurable CPM or TSP abnormalities.

What neurobiological mechanisms linking sleep disturbance and pain were discussed by Herrero Babiloni et al. (2020)?

Herrero Babiloni et al. (2020) reviewed several interacting mechanisms that may explain the sleep–pain relationship.

1. Endogenous pain modulation: • Reduced pain inhibition and potentially increased pain facilitation.

2. Inflammation: • Altered inflammatory signalling and possible neuroinflammatory contributions to nociceptive sensitivity.

3. Psychological processes: • Negative affect, anxiety, depression and catastrophising may intensify pain-related distress.

4. Neurochemical systems: • Dopamine, melatonin and orexin systems may influence pain regulation, arousal and sleep.

5. Brain activity and connectivity: • Altered functioning of sensory, affective and pain-modulatory networks.

6. Sleep microstructure: • Disturbances in sleep stability and repeated microarousals may contribute to the relationship.

These mechanisms are not equally established and should not all be presented as proven causal pathways in humans.

How might inflammatory and neurochemical mechanisms explain the relationship between sleep loss and pain?

Inflammatory mechanisms: • Sleep disturbance may alter immune regulation and increase pro-inflammatory signalling. • Mediators such as IL-6 and TNF-alpha have been implicated in sleep-related changes in pain sensitivity. • Neuroinflammatory processes may contribute to sensitisation.

Neurochemical mechanisms: • Dopamine influences reward, motivation and aspects of pain processing. • Melatonin helps regulate circadian rhythms and may influence nociceptive processing. • Orexin participates in arousal regulation and may also influence pain-modulatory pathways.

Interpretation: • Sleep disruption may affect pain through interacting immune, circadian and neurotransmitter systems.

Limitation: • Evidence for involvement of these systems does not establish that each mechanism mediates sleep-related hyperalgesia in human chronic pain.

How might changes in brain activity and psychological processes contribute to sleep-related pain amplification?

Brain mechanisms: • Sleep deprivation has been associated with altered activity in regions involved in sensory and affective pain processing, including the somatosensory cortex, thalamus and insula. • Changes in connectivity between pain-related and regulatory networks may affect how nociceptive information is processed.

Psychological mechanisms: • Poor sleep may increase negative affect, anxiety and difficulties regulating emotion. • Catastrophising and heightened threat appraisal may amplify pain unpleasantness and interference. • Reduced positive affect may weaken psychological resources for coping.

Interpretation: • Sleep-related pain amplification may reflect interacting changes in nociceptive processing, emotional regulation and cognitive appraisal rather than one isolated biological pathway.

How can Herrero Babiloni et al. (2020) be critically evaluated and integrated with Herrero Babiloni et al. (2024)?

Herrero Babiloni et al. (2020): • Provides a broad mechanistic framework integrating pain modulation, inflammation, neurochemistry, brain networks and psychological processes. • Helps explain why sleep disturbance could affect pain through multiple pathways. • As a narrative review, it cannot establish that every proposed mechanism is causal or equally supported.

Herrero Babiloni et al. (2024): • More directly evaluates empirical evidence linking sleep disturbance with endogenous pain modulation. • Finds suggestive individual-study evidence but no consistent statistically significant overall pooled association for CPM or TSP.

Combined interpretation: • The 2020 review explains plausible mechanisms. • The 2024 review tests the consistency of evidence for one important class of those mechanisms.

Essay implication: • A biologically plausible explanation is not the same as a consistently demonstrated empirical effect. The sleep–pain relationship is likely multifactorial, and the contribution of specific mechanisms remains uncertain.

Why is improving sleep considered a potentially useful intervention for chronic pain?

Sleep disturbance and chronic pain can reinforce one another, making sleep a potentially modifiable treatment target.

• Experimental evidence indicates that sleep loss can increase pain sensitivity. • Prospective evidence links frequent sleep problems with greater subsequent risk of chronic pain. • Improving sleep may reduce fatigue, psychological distress and the wider burden of chronic pain. • Better sleep may improve daily functioning and quality of life even when pain intensity remains relatively unchanged.

Clinical implication: Sleep interventions should be evaluated for their effects on both sleep and pain-related outcomes rather than assuming that improving one necessarily improves the other.

What is cognitive behavioural therapy for insomnia (CBT-I), and how does it work?

CBT-I is a structured psychological treatment targeting thoughts and behaviours that maintain insomnia.

Typical components include: • Stimulus control to strengthen the association between bed and sleep. • Sleep restriction or sleep compression to consolidate sleep. • Cognitive techniques to challenge unhelpful beliefs and worries about sleep. • Relaxation strategies to manage arousal. • Sleep education and behavioural routines that support consistent sleep.

CBT-I aims to improve sleep by changing maintaining mechanisms rather than simply providing general advice about sleep hygiene.

Why might CBT-I be beneficial for people with chronic pain?

• Improved sleep continuity may reduce the consequences of repeated sleep disruption. • Better sleep may reduce fatigue and improve daytime functioning. • Cognitive strategies may reduce worry and unhelpful beliefs about sleep. • Improved sleep may support emotional regulation and coping with persistent pain. • Reducing insomnia may improve quality of life even without a substantial reduction in pain intensity.

However, these are potential pathways and benefits rather than proof that CBT-I directly reverses central sensitisation or reliably reduces chronic pain.

What was the aim and design of the Malfliet et al. trial of CBT-I for chronic spinal pain?

The Malfliet et al. trial investigated whether adding cognitive behavioural therapy for insomnia to best-evidence pain management improved outcomes for patients with nonspecific chronic spinal pain and comorbid insomnia.

• Design: Multicentre randomised controlled clinical trial. • Experimental condition: CBT-I integrated with best-evidence pain management (CBTi-BEPM). • Active control: Best-evidence pain management alone (BEPM). • Participants were screened for underlying sleep disorders using polysomnography. • Outcomes included pain intensity, insomnia severity, sleep quality and psychological functioning. • Follow-up extended to 12 months.

The active comparison tested whether CBT-I provided additional benefit beyond an established pain management intervention.

What did the Malfliet et al. trial find for its primary pain-intensity outcome?

At the 12-month primary endpoint:

• The CBTi-BEPM group showed an approximately 40% reduction in pain intensity. • The BEPM-only group showed an approximately 24% reduction. • Despite the numerical difference, the between-group difference was not statistically significant.

Interpretation: • Both groups improved in pain intensity. • Adding CBT-I was not demonstrated to produce a statistically significant additional reduction in the primary pain outcome.

Critical distinction: A larger numerical improvement is not sufficient evidence of treatment superiority when the between-group comparison is not statistically significant.

What did the Malfliet et al. trial find for sleep-related and psychological outcomes?

Compared with best-evidence pain management alone, the integrated CBTi-BEPM intervention produced greater improvements in several self-reported secondary outcomes.

These included: • Insomnia severity. • Overall sleep quality. • Dysfunctional beliefs about sleep. • Physical fatigue. • Depressive symptoms.

However, objective sleep parameters measured through polysomnography did not show significant between-group differences.

Interpretation: Adding CBT-I appears particularly useful for subjective insomnia symptoms and aspects of psychological wellbeing, even when additional benefits for pain intensity or objective sleep measurements are not demonstrated.

Why is the distinction between subjective and objective sleep outcomes important in the Malfliet et al. trial?

Subjective measures assess how patients experience their sleep, including insomnia severity, sleep quality and sleep-related distress.

Objective measures such as polysomnography assess physiological features of sleep, including sleep stages and continuity.

In the Malfliet trial: • CBTi-BEPM improved several self-reported sleep outcomes relative to BEPM alone. • Significant between-group differences were not demonstrated for objective polysomnography outcomes.

Interpretation: • CBT-I may improve the experience and perceived burden of insomnia without producing corresponding detectable changes in all physiological sleep measures. • Subjective improvement is clinically meaningful, but it should not be described as objective restoration of sleep architecture.

What were the methodological strengths of the Malfliet et al. trial?

• Randomised multicentre design strengthened the evaluation of treatment effects across clinical settings. • An active BEPM comparison provided a more demanding test than a waiting-list or no-treatment control. • Twelve-month follow-up assessed whether outcomes persisted beyond the immediate intervention. • Polysomnography was used to screen participants for underlying sleep disorders. • Treatment fidelity, adherence and therapeutic alliance were monitored. • Outcome assessors and statisticians were blinded, reducing some sources of bias.

Overall, the study provides clinically relevant evidence about the added value of CBT-I when combined with an established chronic pain treatment.

How can the Malfliet et al. trial be critically evaluated?

Strengths: • Randomised multicentre design with a high-quality active comparison. • Long-term follow-up and monitoring of treatment fidelity. • Assessment of both pain outcomes and subjective and objective sleep outcomes.

Limitations: • Excluding patients with obesity or depression limits generalisability to the broader chronic pain population. • Treating physiotherapists could not be blinded to the intervention. • Multiple secondary outcomes were examined without adjustment for multiple comparisons, increasing the possibility of chance significant findings. • Objective sleep assessment was limited, including reliance on a single night of polysomnography. • Missing data occurred because of technical difficulties and the COVID-19 pandemic.

Essay implication: • The trial supports CBT-I for improving insomnia-related outcomes in chronic pain patients, but does not establish additional superiority for the primary pain-intensity outcome.

What do sleep intervention findings suggest about the clinical importance of treating insomnia in chronic pain?

The wider evidence suggests that sleep is an important treatment target, but improvements in sleep and pain should not be treated as interchangeable.

• Chang et al. (2022) found that experimentally disrupting sleep can increase pain sensitivity. • Herrero Babiloni et al. (2025) found that frequent sleep problems prospectively predict chronic pain incidence. • Herrero Babiloni et al. (2024) found inconsistent pooled evidence linking sleep disturbance with altered endogenous pain modulation. • The Malfliet et al. trial found additional improvements in subjective insomnia outcomes from CBT-I but not a statistically significant additional improvement in its primary pain-intensity outcome.

Overall conclusion: • Sleep disturbance is clinically important in its own right. • Treating insomnia may improve wellbeing and functioning without necessarily producing greater analgesia. • Evidence that sleep treatment prevents chronic pain or reverses particular pain-modulatory mechanisms remains insufficient.

How do stress and chronic pain interact according to Timmers et al. (2019)?

Timmers et al. (2019) propose that stress and chronic pain interact through overlapping biological and psychological mechanisms, particularly threat learning.

• Stress can increase vigilance towards potentially threatening bodily sensations. • Pain-related fear and catastrophising may activate physiological stress responses. • Stress may promote avoidance and interfere with flexible, goal-directed behaviour. • Stress-related changes in learning and memory may strengthen pain-related threat associations.

The review identifies overlapping corticolimbic regions, including the amygdala, hippocampus, medial prefrontal cortex and thalamus.

Central argument: Stress may contribute to the persistence of pain-related fear and disability through its influence on threat perception, behaviour and learning.

What is the difference between the sympathetic-adrenal-medullary (SAM) system and the hypothalamic-pituitary-adrenal (HPA) axis?

The SAM system produces a rapid autonomic response to stress.

• Activates the sympathetic nervous system. • Promotes release of adrenaline and noradrenaline. • Increases heart rate, alertness and physiological arousal. • Operates rapidly, typically within seconds.

The HPA axis produces a slower endocrine response.

• Involves sequential activation of the hypothalamus, pituitary gland and adrenal cortex. • Results in cortisol release. • Influences metabolism, physiological stress regulation and learning processes. • Develops over a longer timescale than the immediate SAM response.

Both systems contribute to stress responses but operate through different physiological pathways and timescales.

What are the stages of HPA axis activation during stress?

1. A stressor activates the hypothalamus.
2. The hypothalamus releases corticotropin-releasing hormone (CRH).
3. CRH stimulates the anterior pituitary gland to release adrenocorticotropic hormone (ACTH).
4. ACTH travels through the bloodstream to the adrenal cortex.
5. The adrenal cortex releases cortisol.
6. Cortisol contributes to the physiological stress response and participates in feedback regulation of HPA axis activity.

Relevance to chronic pain: Stress-related cortisol activity may influence pain processing, threat learning and behavioural responses to pain.

What are the four points of contact between stress and the fear-avoidance model proposed by Timmers et al. (2019)?

1. Threat perception: • Stress may increase attention to threatening stimuli, making pain or potential injury appear more threatening.

2. Pain-related distress and HPA activation: • Catastrophising and fear may facilitate physiological stress responses, which can also influence pain experience.

3. Goal-directed behaviour: • Stress may compromise flexible, values-based behaviour and favour rigid avoidance or immediate pain-control strategies.

4. Threat learning: • Stress may alter the acquisition, generalisation, reconsolidation and extinction of threat-related memories.

Overall, the model proposes that stress interacts with several stages of the fear-avoidance cycle rather than influencing pain through a single pathway.

How can stress influence threat perception and pain-related distress according to Timmers et al. (2019)?

Threat perception: • Stress may increase vigilance and attentional prioritisation of potentially harmful stimuli. • Painful sensations or movements may consequently be interpreted as more threatening.

Pain-related distress: • Catastrophising, fear and worry may facilitate activation of the HPA axis. • Physiological stress responses may, in turn, influence pain experience.

Importantly, stress can be associated with either increased or decreased pain sensitivity depending on the circumstances.

Interpretation: Pain-related threat appraisal and physiological stress responses may reinforce one another, although the direction and strength of these effects are context-dependent.

How can stress promote inflexible behaviour and maintain fear-avoidance in chronic pain?

Timmers et al. (2019) propose that stress may compromise flexible, goal-directed behaviour.

• Goal-directed behaviour involves selecting actions according to longer-term goals and expected outcomes. • Under stress, behaviour may become more habitual, rigid or focused on immediate threat reduction. • Patients may prioritise guarding, avoiding movement or controlling pain over valued activities. • Avoidance may provide short-term relief but maintain disability by limiting opportunities for corrective learning.

Clinical implication: Rehabilitation may need to address stress and threat appraisal alongside activity goals to support more flexible behaviour.

How can stress affect the acquisition, generalisation, reconsolidation and extinction of pain-related threat memories?

Timmers et al. (2019) discuss four learning processes.

1. Acquisition: • Stress may facilitate learning associations between painful experiences and threatening cues.

2. Generalisation: • Fear may spread from genuinely threatening situations to similar but relatively safe situations.

3. Reconsolidation: • Stress during memory reactivation may influence how established threat memories are updated or strengthened.

4. Extinction: • Stress may interfere with learning or retrieving new safety associations when a feared cue is no longer followed by harm.

These effects depend on the timing and context of stress rather than occurring identically in every situation.

How do the rapid and delayed effects of cortisol influence threat-related learning?

Timmers et al. (2019) distinguish two broad phases of cortisol action.

Rapid non-genomic effects: • Can facilitate encoding and early consolidation of stressor-related information. • May support formation of emotionally salient threat memories.

Delayed genomic effects: • Can favour consolidation and storage of stressor-related information. • May reduce interference from unrelated information.

Relevance to pain: • If pain or movement is appraised as highly threatening, stress-related changes in memory processing may strengthen learned threat associations.

Critical point: Cortisol's effects on learning are dependent on timing, context and the type of information being learned.

How do classical and operant conditioning contribute to pain-related fear and avoidance?

Classical conditioning: • A previously neutral movement or situation becomes associated with pain. • The movement can subsequently elicit fear even before pain occurs. • Fear may generalise to other movements and persist when safety learning is impaired.

Operant conditioning: • A painful consequence may reduce the likelihood of repeating an activity through punishment. • Avoiding an activity may reduce anticipated pain or fear. • This relief can negatively reinforce avoidance, making it more likely to recur.

Together, these processes help explain how pain-related fear and avoidance can persist beyond the original painful experience.

What abnormalities in threat learning are discussed in relation to chronic pain?

Timmers et al. (2019) discuss several possible alterations in threat learning among people with chronic pain.

• Reduced differential learning: Difficulty distinguishing cues associated with threat from cues associated with safety. • Fear overgeneralisation: Fear responses extend to stimuli or movements resembling previously threatening situations. • Impaired extinction: Difficulty learning or retrieving that a previously threatening cue is now safe. • Persistent avoidance: Short-term relief from avoiding activities reinforces the behaviour.

These processes may maintain pain-related disability.

However, they are not necessarily present in every chronic pain patient and should not be treated as universal abnormalities.

How can Timmers et al. (2019) be critically evaluated?

Strengths: • Integrates biological stress systems with psychological learning mechanisms and the fear-avoidance model. • Explains how stress could influence pain-related disability through several interacting processes. • Identifies clinically relevant mechanisms such as threat generalisation, avoidance and extinction learning.

Limitations: • It is a theoretical review rather than a single experimental test of the complete integrated model. • Evidence for particular stress effects on learning may come from contexts that do not fully reproduce chronic pain. • Stress effects vary with timing, context and individual differences. • The model cannot establish that HPA axis changes directly cause pain chronification.

Essay implication: • Provides a plausible biopsychosocial framework, but its proposed pathways require direct empirical testing in chronic pain populations.

What was the aim and methodology of Vyverman et al. (2026)?

Vyverman et al. (2026) conducted a preregistered systematic review and meta-analysis investigating relationships between physiological stress markers and experimental pain responses in chronic primary pain.

• Included 52 studies involving 2,657 participants. • Studies were predominantly case-control, alongside a smaller number of cross-sectional studies. • Included chronic widespread pain or fibromyalgia and chronic localised pain populations. • Examined autonomic nervous system and HPA axis markers. • Physiological measures included blood pressure, heart rate, heart rate variability and cortisol. • Pain outcomes included experimental thresholds, tolerance and dynamic pain modulation.

The review examined resting stress physiology, responses during stress and recovery following stress exposure.

What were the main findings of Vyverman et al. (2026) concerning physiological stress markers and pain sensitivity?

The review found some significant associations between physiological stress markers and experimental pain sensitivity.

• Lower resting mean arterial pressure was associated with greater electrical pain sensitivity. • Higher resting or stress-related heart rate was associated with lower pressure pain thresholds in some analyses. • Higher resting cortisol was associated with lower pressure pain thresholds. • Lower high-frequency heart rate variability during recovery was associated with lower cold pain tolerance.

However: • Findings varied across measures and testing conditions. • Evidence linking acute changes in physiological stress responses with acute changes in pain outcomes was sparse. • Pooled analyses of these change-related associations did not demonstrate significant relationships.

Interpretation: Physiological stress regulation is associated with aspects of pain sensitivity, but the relationship is complex and inconsistent.

What mechanisms might explain associations between stress physiology and pain sensitivity in chronic primary pain?

Vyverman et al. (2026) discuss several possible mechanisms.

1. Baroreceptor-related pain modulation: • Blood pressure and baroreceptor activity may interact with endogenous pain inhibition. • Associations between lower mean arterial pressure and greater pain sensitivity are compatible with altered cardiovascular pain modulation.

2. Autonomic regulation: • Higher heart rate and lower recovery-related heart rate variability may reflect differences in autonomic activity associated with pain sensitivity.

3. HPA axis functioning: • Associations between resting cortisol and pain thresholds may indicate altered endocrine stress regulation.

Important limitation: • These physiological associations do not demonstrate that the proposed mechanisms directly cause heightened pain sensitivity.

How can Vyverman et al. (2026) be critically evaluated and integrated with Timmers et al. (2019)?

Strengths of Vyverman et al.: • Systematic and preregistered review covering multiple physiological stress markers and pain outcomes. • Considered baseline, stress reactivity and recovery rather than treating stress physiology as a single measurement. • Provides empirical evidence relevant to proposed stress–pain mechanisms.

Limitations: • Most included studies were observational or case-control, preventing causal conclusions. • Many meta-analyses contained only two or three studies. • Stress protocols, pain measures and sampling times varied substantially. • Certainty of evidence ranged from very low to moderate. • The direction of associations between physiological stress markers and pain could not be established.

Integration: • Timmers et al. (2019) propose mechanisms through which stress and threat learning may contribute to chronic pain. • Vyverman et al. (2026) provide some empirical support for associations between stress physiology and pain sensitivity, but show that the evidence remains inconsistent.

Essay implication: • Stress is relevant to chronic pain, but physiological associations should not be presented as proof of a single causal stress–pain pathway.

What was the aim and central argument of Elma et al. (2022)?

Elma et al. (2022) conducted a narrative review examining nutrition as a modifiable lifestyle factor in chronic pain management.

The review considered: • Nutritional status and eating behaviours among people with chronic pain. • Potential physiological mechanisms linking nutrition with pain. • Nutritional screening, assessment and interventions in clinical practice.

Central argument: • Poor nutritional status may contribute to the development or maintenance of chronic pain. • Chronic pain may also adversely affect nutritional intake and health. • Nutrition should therefore be considered within interdisciplinary biopsychosocial pain management rather than treated as unrelated to pain.

How is the relationship between nutrition and chronic pain bidirectional?

Nutrition may influence pain: • Poor diet quality and nutritional deficiencies may contribute to inflammatory and metabolic processes associated with pain. • Body weight and muscle mass can affect physical functioning and mechanical loading. • Nutritional status may influence overall health and recovery.

Chronic pain may influence nutrition: • Pain and disability can make shopping, preparing food and eating more difficult. • Reduced appetite, gastrointestinal symptoms and medication effects may alter dietary intake. • Reduced physical activity and psychological distress may contribute to changes in eating behaviours.

Overall, nutrition and pain can influence one another through interacting biological, psychological and behavioural processes.

What is the relationship between body weight, nutritional status and chronic pain according to Elma et al. (2022)?

The review discusses associations between chronic pain and both excess body weight and undernutrition.

Excess body weight: • May increase mechanical loading, particularly in weight-bearing joints. • Adipose tissue can influence inflammatory and metabolic signalling. • Obesity is associated with greater pain interference and functional limitations in some populations.

Undernutrition: • May contribute to muscle loss, weakness and reduced physical functioning. • Can be particularly relevant among older adults experiencing sarcopenia or frailty.

Clinical implication: • Nutritional assessment should consider overall health, body composition and functional needs rather than focusing exclusively on weight loss.

These associations do not establish that body weight alone causes chronic pain.

How might inflammation and oxidative stress link nutrition to chronic pain?

Elma et al. (2022) discuss inflammation and oxidative stress as potential mechanisms.

• Some dietary patterns may contribute to increased oxidative stress and inflammatory signalling. • Reactive oxygen species can contribute to oxidative damage when antioxidant defences are insufficient. • Pro-inflammatory mediators such as IL-6 and TNF-alpha may influence nociceptive processing. • Inflammatory processes may contribute to peripheral or central sensitisation. • Nutrients with antioxidant properties may help regulate oxidative processes.

Interpretation: • Diet may influence pain partly through immune and inflammatory pathways.

Limitation: • These mechanisms are biologically plausible but do not establish that particular foods directly cause or reverse central sensitisation in humans.

How might the microbiota–gut–brain axis contribute to the relationship between nutrition and chronic pain?

The microbiota–gut–brain axis refers to bidirectional communication between intestinal microorganisms, the gastrointestinal system and the nervous system.

• Dietary patterns influence the composition and activity of gut microorganisms. • Changes in gut microbiota may affect intestinal and systemic inflammatory signalling. • Communication between the gut and brain involves neural, immune and metabolic pathways. • These processes may influence nociceptive processing and pain-related symptoms.

Elma et al. (2022) discuss gut dysbiosis as a potential contributor to pain through altered inflammatory and neural signalling.

Critical point: • The involvement of the gut–brain axis does not establish that microbiome changes cause chronic pain or that dietary manipulation reliably reverses it.

How might disturbed glucose and lipid metabolism contribute to chronic pain?

Glucose metabolism: • Dietary patterns may influence blood glucose regulation and insulin sensitivity. • Impaired glucose metabolism is associated with some chronic musculoskeletal pain conditions. • Metabolic dysfunction may contribute to oxidative stress and inflammatory signalling.

Lipid metabolism: • Altered cholesterol and triglyceride profiles may influence vascular and inflammatory processes. • The review discusses possible associations between lipid abnormalities, tendon health and musculoskeletal pain. • Vascular mechanisms have been proposed in relation to chronic low back pain.

Interpretation: • Metabolic health may influence pain through several interacting pathways.

However, associations between metabolic markers and pain do not establish a direct causal relationship.

How can obesity contribute to chronic pain through mechanical and inflammatory mechanisms?

Mechanical mechanisms: • Greater loading on weight-bearing joints may increase physical strain and contribute to some musculoskeletal pain conditions.

Inflammatory mechanisms: • Adipose tissue is metabolically active and releases signalling molecules, including adipokines. • Excess adiposity may be associated with chronic low-grade inflammation. • Inflammatory processes may influence nociceptive sensitivity.

Additional biopsychosocial factors: • Reduced mobility, poor sleep, psychological distress and barriers to participation may also contribute to pain-related disability.

Clinical implication: • Obesity-related pain should not be explained solely through mechanical loading or treated as a simple consequence of body weight.

What role might epigenetic mechanisms play in the relationship between nutrition and chronic pain?

Epigenetic mechanisms influence gene expression without changing the underlying DNA sequence.

Elma et al. (2022) discuss the possibility that dietary factors influence epigenetic processes involved in inflammation.

• DNA methylation is one mechanism through which gene expression may be regulated. • Dietary composition may influence inflammatory gene regulation. • Nutrients such as omega-3 fatty acids and dietary polyphenols have been investigated for potential epigenetic effects.

Proposed implication: • Nutrition may influence inflammatory processes through changes in gene regulation.

Critical limitation: • Evidence for epigenetic effects does not demonstrate that dietary interventions produce clinically meaningful pain relief through these mechanisms in humans.

What nutritional deficiencies and eating behaviours are discussed by Elma et al. (2022) in relation to chronic pain?

The review discusses reported associations between chronic pain and nutritional factors including:

• Lower levels of nutrients such as vitamin D, vitamin B12, magnesium, zinc and omega-3 fatty acids in some populations. • Dietary patterns involving higher consumption of added sugars, saturated fats or energy-dense foods. • Reduced fruit and vegetable intake in some longitudinal observations. • Appetite loss, gastrointestinal difficulties and reduced food intake among certain patient groups. • Muscle loss and nutritional vulnerability among some older adults with chronic pain.

Clinical implication: • Nutritional assessment may identify treatable deficiencies or difficulties maintaining adequate intake.

However, not every person with chronic pain has these nutritional characteristics, and supplementation should not be assumed to reduce pain without evidence of benefit.

What nutritional assessment and management strategies are recommended by Elma et al. (2022)?

Assessment: • Screen for malnutrition and changes in body weight. • Consider dietary quality, nutritional deficiencies and relevant medical conditions. • Identify gastrointestinal symptoms and barriers to obtaining or preparing food. • Use validated nutritional screening tools where appropriate.

Management: • Encourage nutritionally adequate and sustainable eating patterns. • Consider dietary patterns rich in vegetables, fruit, wholegrains and healthy fats. • Address specific deficiencies and nutritional needs. • Refer patients requiring specialist dietary management to a qualified dietitian.

Clinical implication: • Nutrition should be integrated into multidisciplinary pain management and individualised according to patient needs.

The review discusses Mediterranean and plant-based dietary patterns as potentially beneficial, but does not establish one universally effective analgesic diet.

How can Elma et al. (2022) be critically evaluated?

Strengths: • Integrates nutrition into a biopsychosocial understanding of chronic pain. • Considers multiple mechanisms, including inflammation, metabolism and gut–brain communication. • Recognises that both excess body weight and undernutrition may be clinically relevant. • Highlights the importance of nutritional screening and interdisciplinary care.

Limitations: • As a narrative review, it does not provide the same systematic evidence appraisal or pooled effect estimates as a meta-analysis. • Much of the evidence linking nutritional factors to pain is observational. • Associations may be influenced by confounding variables such as physical activity, sleep, socioeconomic circumstances and comorbidities. • Proposed molecular mechanisms may not translate directly into clinically meaningful improvements in pain. • Different chronic pain conditions may respond differently to dietary interventions.

Essay implication: • Nutrition is a plausible and clinically relevant treatment target, but stronger controlled intervention evidence is needed before specific dietary approaches can be described as established analgesic treatments.

How can nutrition be integrated with physical activity, sleep and psychological approaches in chronic pain management?

A biopsychosocial approach recognises that lifestyle factors interact rather than operating independently.

• Physical activity may influence pain modulation, functioning and confidence in movement. • Sleep management may improve insomnia symptoms, fatigue and psychological wellbeing. • Stress management may address threat appraisal and avoidance behaviours. • Nutritional support may improve dietary adequacy, metabolic health and overall functioning.

These factors can also influence one another: • Pain-related fatigue may reduce physical activity and food preparation. • Poor sleep and stress may affect eating behaviours. • Disability may make maintaining healthy routines more difficult.

Overall conclusion: • Lifestyle approaches should be individualised and integrated into multidisciplinary pain management. • Improvements in wellbeing and function are valuable even when pain intensity is not substantially reduced. • The effectiveness of a combined approach should not be assumed to equal the sum of its individual components without direct evidence.